ArticleCancers2024

Comparison of Treatment Outcomes Between First-Line Chemotherapy With or Without Bevacizumab for Advanced Ovarian Clear Cell Carcinoma (Tohoku Gynecologic Cancer Unit: TGCU-RS001A Study).

Tadahiro Shoji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.